Dr Kishore is deeply integrated into the Midlands clinical research landscape, serving as a principal investigator for numerous Phase II and III clinical trials. His work focuses on translating bench-side innovations into bedside therapies, with a specific emphasis on advancing multiple myeloma treatments and optimising patient outcomes in complex bone marrow transplantations.